Supply chain planning for pharmaceutical companies in Southeast Asia has been saved
Supply chain planning for pharmaceutical companies in Southeast Asia
A focus on Sales & Operations Planning
It is little surprise that when it comes to supply chain metrics such as capacity utilisation and inventory turnover rates, the pharmaceutical sector lags behind many others.
Even as industry players recognise supply chain planning as crucial to delivering competitive advantage, their traditional approach of working in silos results in an environment where short-term supply issues often consume all the attention.
As a result, maintaining a long-term, strategic focus on profitable growth and cultivating a collaborative culture are priorities that tend to be relegated to the backseat. For pharmaceutical companies in Southeast Asia, this picture is further complicated by the unrelenting external pressures on top-line revenues, in the form of an increased focus on generics and cost containment, as well as constantly evolving Essential Drugs Lists.
Given the increasing demand-supply complexity and the introduction of multi-tier pricing regulations, Sales & Operations Planning (S&OP) is now an endeavour that is equal parts science and art. With the experience of deploying S&OP initiatives across the Southeast Asia region, this publication presents five planning hurdles that pharmaceutical companies should focus on, and the corresponding strategies to overcome them.